中文(简体)
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Effect of Green Tea on Treatment of Lupus

只有注册用户可以翻译文章
登陆注册
链接已保存到剪贴板
状态已完成
赞助商
Ahvaz Jundishapur University of Medical Sciences

关键词

抽象

This randomized double blind clinical trial performed on 68 patients (32 in intervention and 36 in control group) diagnosed with SLE. The patients in intervention group were given daily dose of 1000mg of aqueous green tea extract (of 6 gram of dried green tea leaf) in form of two capsules ( 500 mg). Also in control group, the patients were given daily dose of 1000mg of cellulose in form of two capsules ( 500 mg) Variables include SLE disease activity, some biomarkers of inflammation and oxidative stress and anthropometric indicators at baseline and end of the study.
The investigators used SLEDAI (systemic lupus erythematous disease activity index ) questionnaire for evaluating the clinical signs of the disease. The questionnaires filled out at baseline and after 3 month.

描述

noting

日期

最后验证: 04/30/2016
首次提交: 05/27/2016
提交的预估入学人数: 08/17/2016
首次发布: 08/22/2016
上次提交的更新: 08/17/2016
最近更新发布: 08/22/2016
实际学习开始日期: 08/31/2015
预计主要完成日期: 02/29/2016
预计完成日期: 02/29/2016

状况或疾病

Autoimmune
Lupus Erythematosus, Systemic

干预/治疗

Dietary Supplement: green tea extract

Dietary Supplement: Placebo

相 2

手臂组

干预/治疗
Active Comparator: green tea extract
Patients were given daily dose of 1000mg aqueous green tea extract (of 6 grams of dried green tea leaf) in the form of 2 capsules (500 mg) for three months.
Dietary Supplement: green tea extract
Patients are given daily dose of 1000mg aqueous green tea extract (of 6 grams of dried green tea leaf) in the form of 2 capsules( 500 mg) for three months.
Placebo Comparator: Placebo
Patients in placebo group received daily dose of 1000 mg cellulose in the form of 2 capsules (500 mg) for three months
Dietary Supplement: Placebo
Patients in placebo group receive daily dose of 1000 mg cellulose in the form of 2 capsules (500 mg) for three months

资格标准

有资格学习的年龄 15 Years 至 15 Years
有资格学习的性别Female
接受健康志愿者
标准

Inclusion Criteria:

The patients older than 15 years,diagnosed with systemic lupus erythematous (SLE) according to ACR(American College of Rheumatology) criteria.

Exclusion Criteria:

- Patients with other autoimmune diseases (diabetes, ...)

- Cardiovascular disease

- Patients with infectious or liver disease;

- severe infection

- Pregnancy

- Breastfeeding

- Smoking

- Alcohol consumption

- Use of any dietary supplements

- Changing of medication during the study period

结果

主要结果指标

1. systemic lupus erythematous Disease Activity [Three months after starting of intervention]

Clinical signs consist of 24 items, 16 of which are clinical items such as seizure, psychosis, organic brain syndrome, visual disturbance, other neurological problems, hair loss, new rash, muscle weakness, arthritis, blood vessel inflammation, mouth sores, chest pain worse with deep breathing and manifestations of pleurisy and/or pericarditis and fever consistency.Eight of the 24 items are laboratory results such as urinalysis testing, blood complement levels, increase anti-DNA antibody levels, low platelets, and low white blood cell count. these items assessed by SLEDAI questionnaire

次要成果指标

1. measurement of some proinflammatory and anthropometric markers [At baseline and after three months of intervention]

interleukin-6 (IL6), interleukin1β(IL1β , Tumor Necrosis Factor-α (TNF-α),Total Antioxidant Capacity (TAC) of Blood serum will be assessed by enzyme-linked immunosorbent assay (ELISA) at baseline and after three months intervention • Malondialdehyde (MDA) Blood serum MDA will be assessed by Thiobarbituric acid method (TBA)

2. Health-Related Quality of Life [At baseline and after three months of intervention]

Quality of Life will be assessed by12-item Short-Form (SF-12v2) self-report questionnaire ,at baseline and after3 months of intervention

其他成果措施

1. Dietary intake [at baseline and after 3 month of intervention]

24-Hour dietary recalls questionnaires will be used to assess dietary pattern

2. Weight [at baseline and after 3 month of intervention]

Weight will be measured in kg

3. BMI [at baseline and after 3 month of intervention]

BMI is weight in kilograms divided to height in meters squared

加入我们的脸书专页

科学支持的最完整的草药数据库

  • 支持55种语言
  • 科学支持的草药疗法
  • 通过图像识别草药
  • 交互式GPS地图-在位置标记草药(即将推出)
  • 阅读与您的搜索相关的科学出版物
  • 通过药效搜索药草
  • 组织您的兴趣并及时了解新闻研究,临床试验和专利

输入症状或疾病,并阅读可能有用的草药,输入草药并查看所使用的疾病和症状。
*所有信息均基于已发表的科学研究

Google Play badgeApp Store badge